Prof David R. Ferry
Prof David R. Ferry
VP-Gastrointestinal Oncology
Verified email at
Cited by
Cited by
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo …
CS Fuchs, J Tomasek, CJ Yong, F Dumitru, R Passalacqua, C Goswami, ...
The Lancet 383 (9911), 31-39, 2014
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a …
H Wilke, K Muro, E Van Cutsem, SC Oh, G Bodoky, Y Shimada, ...
The lancet oncology 15 (11), 1224-1235, 2014
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously …
E Van Cutsem, J Tabernero, R Lakomy, H Prenen, J Prausová, ...
J Clin Oncol 30 (28), 3499-3506, 2012
ZD1839, a selective oral epidermal growth factor receptor–tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I …
M Ranson, LA Hammond, D Ferry, M Kris, A Tullo, PI Murray, V Miller, ...
Journal of Clinical Oncology 20 (9), 2240-2250, 2002
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label …
T Waddell, I Chau, D Cunningham, D Gonzalez, AFC Okines, ...
The lancet oncology 14 (6), 481-489, 2013
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
DR Ferry, A Smith, J Malkhandi, DW Fyfe, PG deTakats, D Anderson, ...
Clinical cancer research: an official journal of the American Association …, 1996
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
MT Seymour, TS Maughan, JA Ledermann, C Topham, R James, ...
The Lancet 370 (9582), 143-152, 2007
Mitomycin, ifosfamide, and cisplatin in unresectable non–small-cell lung cancer: Effects on survival and quality of life
MH Cullen, LJ Billingham, CM Woodroffe, AD Chetiyawardana, ...
Journal of Clinical Oncology 17 (10), 3188-3194, 1999
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin
LW Seymour, DR Ferry, D Anderson, S Hesslewood, PJ Julyan, R Poyner, ...
Journal of clinical oncology 20 (6), 1668-1676, 2002
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study
A Ohtsu, JA Ajani, YX Bai, YJ Bang, HC Chung, HM Pan, T Sahmoud, ...
Journal of Clinical Oncology 31 (31), 3935, 2013
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
S Danson, D Ferry, V Alakhov, J Margison, D Kerr, D Jowle, M Brampton, ...
British journal of cancer 90 (11), 2085-2091, 2004
Calcium channels: direct identification with radioligand binding studies
H Glossmann, DR Ferry, F Lübbecke, R Mewes, F Hofmann
Trends in Pharmacological Sciences 3, 431-437, 1982
Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non–small-cell lung cancer
RB Natale, S Thongprasert, FA Greco, M Thomas, CM Tsai, ...
Journal of Clinical Oncology 29 (8), 1059-1066, 2011
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
SJ Dutton, DR Ferry, JM Blazeby, H Abbas, A Dahle-Smith, W Mansoor, ...
The lancet oncology 15 (8), 894-904, 2014
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
LW Seymour, DR Ferry, DJ Kerr, D Rea, M Whitlock, R Poyner, C Boivin, ...
International journal of oncology 34 (6), 1629-1636, 2009
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
DA Fennell, Y Summers, J Cadranel, T Benepal, DC Christoph, R Lal, ...
Cancer treatment reviews 44, 42-50, 2016
Clinical trials of P-glycoprotein reversal in solid tumours
DR Ferry, H Traunecker, DJ Kerr
European journal of cancer 32 (6), 1070-1081, 1996
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified …
J Tabernero, E Van Cutsem, R Lakomý, J Prausová, P Ruff, GA Van Hazel, ...
European journal of cancer 50 (2), 320-331, 2014
[42] Assay for calcium channels
H Glossmann, DR Ferry
Methods in enzymology 109, 513-550, 1985
[3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
P Bellemann, D Ferry, F Lübbecke, H Glossman
Arzneimittel-forschung 31 (12), 2064-2067, 1981
The system can't perform the operation now. Try again later.
Articles 1–20